Lombard Medical, Inc. is a medical technology company. The Company specializes in developing, manufacturing, and marketing endovascular stent-grafts for repair of aortic aneurysms. Its lead product, Aorfix, is an abdominal aortic aneurysm (AAA) stent-graft for the treatment of AAAs with angulation at the neck of the aneurysm of up to 90 degrees. It supplies Aorfix pre-loaded into a delivery system, Aorflex, which is designed for accurate placement of Aorfix in the abdominal aorta. Once Aorfix is placed within the abdominal aorta, it provides a conduit for blood flow, thereby relieving pressure within the weakened or aneurysmal section of the vessel wall, which reduces the potential for the AAA to rupture. Its principal brands are Aorfix and Aorflex. Outside of the United States, it markets Aorfix through its direct sales forces in Germany and the United Kingdom and through distribution agreements with partners in other European Union countries, Latin America and Asia.
